Vimarsana
Biggest News Aggregation in the World

Page 2 - Preclinical Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Preclinical Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Preclinical Testing Today - Breaking & Trending Today

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine - Vimarsana News

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

In a recent study published in The Lancet Microbe journal, researchers described the effectiveness of a modular capsid virus-like coronavirus disease 2019 (COVID-19) vaccination.

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance - Vimarsana News

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

We speak to Matthew Dunne, Director for Drug Discovery at Micreos Pharmaceuticals, about the importance of creating new targeted antibacterial products.

Scientists develop and test a new model of traumatic brain injury in zebrafish - Vimarsana News

Scientists develop and test a new model of traumatic brain injury in zebrafish

A group of scientists, which included researchers from the Ural Federal University (UrFU), have developed and successfully tested a new model of traumatic brain injury (TBI) in zebrafish.

The Global AI in Drug Discovery Market to Surge at a Phenomenal CAGR of 37.67% During the Forecast Period (2022–2027) | DelveInsight - Vimarsana News

The Global AI in Drug Discovery Market to Surge at a Phenomenal CAGR of 37.67% During the Forecast Period (2022–2027) | DelveInsight

The AI in drug discovery market is experiencing favorable market expansion as a result of factors such as increased dis...

New mouse model faithfully mimics brain damage caused by severe Rift Valley Fever virus infection - Vimarsana News

New mouse model faithfully mimics brain damage caused by severe Rift Valley Fever virus infection

A new mouse model identified by virologists from the University of Pittsburgh might revolutionize development of therapies targeting brain inflammation caused by Rift Valley Fever virus (RVFV).